Martin Weltman

University of Sydney — Australia

Medicine · Health Sciences

47h-index11.4kcitations171works5.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis C virus research(83), Liver Disease Diagnosis and Treatment(75), Hepatitis B Virus Studies(39), Liver Diseases and Immunity(18), Systemic Lupus Erythematosus Research(12)

Publications168 total

Autoimmune liver diseases in the Asia Pacific region: proceedings of the autoimmune liver disease course at APASL 2025
Hepatology International·2025· 1 cited
Challenges facing the PBC community: insights from the PBC International Summit
Frontline Gastroenterology·2025Open Access
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial
Nature Medicine·2025· 2 citedOpen Access
Disseminated Histoplasmosis as a Cause of a Small Bowel Mass and Cholestatic Liver Injury in an Immunocompetent Host: A Case Report
Case Reports in Gastroenterology·2025Open Access
Surviving Hepatitis C—Understanding Death and Survival Beyond Cure
Alimentary Pharmacology & Therapeutics·2025· 3 cited
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study
International Journal of Drug Policy·2025· 1 citedOpen Access
LBP-018 Chronic hepatitis B virus infected participants responding to prior BRII-179 treatment achieved faster and higher rate of hepatitis B virus surface antigen seroclearance on elebsiran plus peginterferon-alfa: end of treatment data from ENSURE study
Journal of Hepatology·2025· 2 cited
WED-125 The Liver Frailty Index predicts survival in hepatocellular carcinoma: an australian multicentre prospective cohort study (APriCa study)
Journal of Hepatology·2025
Going against the grain: A case report of histoplasmosis as a cause of cholestatic liver disease
2024Open Access
Alcohol does not impact chronic hepatitis <scp>C</scp> treatment outcomes but increases risk for progressive liver disease: <scp>Findings</scp> from a prospective multicentre <scp>Australian</scp> study (<scp>OPERA‐C</scp>)
Drug and Alcohol Review·2024· 1 citedOpen Access
A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC)
BMC Cancer·2024· 5 citedOpen Access
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?
Hepatology·2024· 27 citedOpen Access
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across Australia
Open Forum Infectious Diseases·2024· 4 citedOpen Access
Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care
Journal of Gastroenterology and Hepatology·2023· 3 citedOpen Access
A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review
Cancers·2023· 5 citedOpen Access
Systematic review: patients with pre-existing chronic liver disease are more vulnerable to the severe sequelae of drug induced liver injury
Journal of Hepatology·2023
Systematic review and meta-analysis: Comparing hepatocellular and cholestatic patterns of drug-induced liver injury
iLiver·2023· 4 citedOpen Access
Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogramming
Metabolism·2023· 32 cited
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs
Value in Health·2023· 6 citedOpen Access
Comparison between PSMA PET/CT and MRI for Characterizing Hepatocellular carcinoma: A Real-World Study
Tomography·2023· 8 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Gregory J. Dore(22), Jacob George(11), Christopher Liddle(11), Elizabeth E. Powell(10), Jason Grebely(10), Wendy Cheng(10), Thomas Berg(9), Margaret Hellard(9), Maria Lorena Abate(8), Ulrich Spengler(8), Stephen M. Riordan(8), Gail Matthews(8), David Sheridan(7), David Booth(7), William L. Irving(7), Golo Ahlenstiel(6), Geoffrey C. Farrell(6), Jacob George(6), Geoffrey W. McCaughan(6), Olav Dalgård(6)